May 1, 2023
Full article: https://www.ajronline.org/doi/abs/10.2214/AJR.22.28970
Leo Jia, MD discusses a new study that finds the time to resolution after a booster dose supports the current recommendation for follow up of at least 12 weeks for suspected vaccine-related lymphadenopathy.